GRP and neoplasm: Fourteen days after the first treatment, the average tumor sizes of mice treated with RGD-targeted nanoparticles, bombesin-targeted nanoparticles, pegylated nanoparticles, and free siRNA were 84.8%, 100.9%, 152.5%, and 170.2% of their initial sizes, respectively.